(Q74409745)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11516503%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

title

Chitosan nanoparticles as delivery systems for doxorubicin (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11516503%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference

1 reference

M P Fresneau

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11516503%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

A Marazuela

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11516503%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

A Fabra

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11516503%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

publication date

1 June 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11516503%20AND%20SRC:MED&resulttype=core&format=json

Journal of Controlled Release

10 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11516503%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

volume

73

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11516503%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

issue

2-3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11516503%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

page(s)

255-267

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11516503%20AND%20SRC:MED&resulttype=core&format=json

Expression of a multidrug resistance gene in human cancers

10 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2801%2900294-2

7 January 2021

Microparticulate drug delivery systems as an adjunct to cancer treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2801%2900294-2

7 January 2021

Albumin microspheres as vehicles for the sustained and controlled release of doxorubicin

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2801%2900294-2

7 January 2021

Pharmacokinetics and tissue distribution of doxorubicin encapsulated in stable liposomes with long circulation times

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2801%2900294-2

7 January 2021

Physical entrapment of adriamycin in AB block copolymer micelles

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2801%2900294-2

7 January 2021

Biodegradable nanoparticles containing doxorubicin-PLGA conjugate for sustained release

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2801%2900294-2

7 January 2021

Toxicity of polyalkylcyanoacrylate nanoparticles II: Doxorubicin-loaded nanoparticles

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2801%2900294-2

7 January 2021

Doxorubicin-loaded nanospheres bypass tumor cell multidrug resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2801%2900294-2

7 January 2021

Significant transport of doxorubicin into the brain with polysorbate 80-coated nanoparticles.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2801%2900294-2

7 January 2021

Acute renal toxicity of doxorubicin (adriamycin)-loaded cyanoacrylate nanoparticles

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2801%2900294-2

7 January 2021

Enhanced transport of nanoparticle associated drugs through natural and artificial membranes--a general phenomenon?

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2801%2900294-2

7 January 2021

Effect of chitosan on the permeability of monolayers of intestinal epithelial cells (Caco-2)

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2801%2900294-2

7 January 2021

Enhancement of nasal absorption of insulin using chitosan nanoparticles

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2801%2900294-2

7 January 2021

In vitro degradation rates of partially N-acetylated chitosans in human serum

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2801%2900294-2

7 January 2021

In vitro approaches for determining mechanisms of toxicity and carcinogenicity by asbestos in the gastrointestinal and respiratory tracts

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2801%2900294-2

7 January 2021

Electronic Absorption Spectra and Protolytic Equilibria of Doxorubicin: Direct Spectrophotometric Determination of Microconstants

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2801%2900294-2

7 January 2021

Evaluation of ion-exchange microspheres as carriers for the anticancer drug doxorubicin: in-vitro studies

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2801%2900294-2

7 January 2021

Iron(III)-adriamycin and Iron(III)-daunorubicin complexes: physicochemical characteristics, interaction with DNA, and antitumor activity

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2801%2900294-2

7 January 2021

EPR studies of copper(II) and cobalt(II) complexes of adriamycin

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2801%2900294-2

7 January 2021

Deciphering the fluorescence signature of daunomycin and doxorubicin.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2801%2900294-2

7 January 2021

10.1016/S0168-3659(01)00294-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11516503%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference